Hoe H[au] - Search Results

Year	Number of Results
1999	1
2001	1
2002	1
2004	3
2005	5
2006	5
2007	3
2008	6
2009	6
2010	8
2011	11
2012	6
2013	6
2014	3
2015	4
2016	3
2017	7
2018	6
2019	3
2020	6
2021	9
2022	8
2023	11
2024	6

1

Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice.

Nam HY, Nam JH, Yoon G, Lee JY, Nam Y, Kang HJ, Cho HJ, Kim J, Hoe HS. Nam HY, et al. Among authors: hoe hs. J Neuroinflammation. 2018 Sep 19;15(1):271. doi: 10.1186/s12974-018-1308-0. J Neuroinflammation. 2018. PMID: 30231870 Free PMC article.

2

Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling.

Kim J, Lee HJ, Park SK, Park JH, Jeong HR, Lee S, Lee H, Seol E, Hoe HS. Kim J, et al. Among authors: hoe hs. Int J Mol Sci. 2021 Sep 30;22(19):10637. doi: 10.3390/ijms221910637. Int J Mol Sci. 2021. PMID: 34638977 Free PMC article.

3

Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β.

Park JH, Hwang JW, Lee HJ, Jang GM, Jeong YJ, Cho J, Seo J, Hoe HS. Park JH, et al. Among authors: hoe hs. Front Immunol. 2023 Jun 26;14:1150940. doi: 10.3389/fimmu.2023.1150940. eCollection 2023. Front Immunol. 2023. PMID: 37435081 Free PMC article.

4

Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling.

Lee HJ, Hoe HS. Lee HJ, et al. Among authors: hoe hs. Pharmacol Res. 2023 Apr;190:106725. doi: 10.1016/j.phrs.2023.106725. Epub 2023 Mar 11. Pharmacol Res. 2023. PMID: 36907286 Free article.

5

Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling.

Kim J, Lee HJ, Park JH, Cha BY, Hoe HS. Kim J, et al. Among authors: hoe hs. J Neuroinflammation. 2022 Jul 15;19(1):187. doi: 10.1186/s12974-022-02549-0. J Neuroinflammation. 2022. PMID: 35841100 Free PMC article.

6

Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling.

Ryu KY, Lee HJ, Woo H, Kang RJ, Han KM, Park H, Lee SM, Lee JY, Jeong YJ, Nam HW, Nam Y, Hoe HS. Ryu KY, et al. Among authors: hoe hs. J Neuroinflammation. 2019 Oct 26;16(1):190. doi: 10.1186/s12974-019-1561-x. J Neuroinflammation. 2019. PMID: 31655606 Free PMC article.

7

Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress.

Rosner S, Valdivia A, Hoe HJ, Murray JC, Levy B, Felip E, Solomon BJ. Rosner S, et al. Among authors: hoe hj. Am Soc Clin Oncol Educ Book. 2023 May;43:e389968. doi: 10.1200/EDBK_389968. Am Soc Clin Oncol Educ Book. 2023. PMID: 37163707 Free article. Review.

8

LASERing FLAURAL Arrangements in Asian EGFR Subsets.

Hoe HJ, Balasubramanian A, John T. Hoe HJ, et al. J Thorac Oncol. 2023 Oct;18(10):1261-1264. doi: 10.1016/j.jtho.2023.07.007. Epub 2023 Sep 11. J Thorac Oncol. 2023. PMID: 37702632 Free article. No abstract available.

9

EGFR is a potential dual molecular target for cancer and Alzheimer's disease.

Choi HJ, Jeong YJ, Kim J, Hoe HS. Choi HJ, et al. Among authors: hoe hs. Front Pharmacol. 2023 Aug 2;14:1238639. doi: 10.3389/fphar.2023.1238639. eCollection 2023. Front Pharmacol. 2023. PMID: 37601068 Free PMC article. Review.

10

Optimizing Dosing of Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better.

Hoe HJ, Solomon BJ. Hoe HJ, et al. J Clin Oncol. 2023 Nov 1;41(31):4849-4851. doi: 10.1200/JCO.23.01768. Epub 2023 Sep 11. J Clin Oncol. 2023. PMID: 37694345 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year